9YF-15165-57138
4 vaccinations
3 coded responses
34 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 029 / RI
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Dose 1 — Pfizer-BioNTech
-
2021-02-28
Registered in v-safe
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-13
-
2021-03-20
Dose 2 — Pfizer-BioNTech
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
-
2021-04-03
Survey response — day 14, dose 2MedDRA: Dyspnoea, Intensive care, Oxygen saturation decreased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Aspired rice. In Respiratory ICU with lung issues. Low O2. Difficult to get breath. Causes unknown. · Healthcare visit (other): Currently in Respiratory ICUMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-06-15
- 2021-06-19
-
2021-06-21
Call successfulDoes not wish to fill out VAERS report
-
2021-09-18
Survey response — 6 months, dose 2MedDRA: Autoimmune haemolytic anaemia, Cardiac failure, Hospitalisation, Hypoxia, Lung opacity, Pneumonia, Pre-existing disease, Respiratory failure, Thrombocytopenia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pfizer Vac 02/27, 03/20.Hosp Adm 03/26-04/09 PE, Pneumonia, Hypoxemic Respiratory Failure, Ground glass opactices lungs. Heparin allergy Thromocytopenia. Hosp Adm 04/14-22 AIHA, Hypoxia, Heart Failure w/ PSF. Hosp Adm 08/20-27 Acute Hypoxemic ResMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-12-30
-
2022-03-03
Dose 4 — Pfizer-BioNTech
- 2022-03-31
- 2022-04-15
- 2022-06-02
-
2022-09-01
Survey response — 6 months, dose 4MedDRA: Blood potassium decreased, Fatigue, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: My potassium level dropped, 2.6. May 2022. I was quite tired. At the time I was taking 20 meq of potassium by mouth. I am seeing a nephrologist · Healthcare visit (other): In person visits.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-01
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
-
2022-09-02
Call successfulParticipant prefers to complete VAERS report online
- 2023-03-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-20 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-03-03 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 6 — day 14, dose 2
Symptoms: Aspired rice. In Respiratory ICU with lung issues. Low O2. Difficult to get breath. Causes unknown.
Healthcare visit (other): Currently in Respiratory ICU
Release 9 — 6 months, dose 2
Symptoms: Pfizer Vac 02/27, 03/20.Hosp Adm 03/26-04/09 PE, Pneumonia, Hypoxemic Respiratory Failure, Ground glass opactices lungs. Heparin allergy Thromocytopenia. Hosp Adm 04/14-22 AIHA, Hypoxia, Heart Failure w/ PSF. Hosp Adm 08/20-27 Acute Hypoxemic Res cut off by CDC
Release 12 — 6 months, dose 4
Symptoms: My potassium level dropped, 2.6. May 2022. I was quite tired. At the time I was taking 20 meq of potassium by mouth. I am seeing a nephrologist
Healthcare visit (other): In person visits.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Intensive care | ✓ | ✓ | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Autoimmune haemolytic anaemia | · | · | ✓ |
| SD | Blood potassium decreased | · | · | ✓ |
| SD | Cardiac failure | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Hypoxia | · | · | ✓ |
| SD | Intensive care | ✓ | ✓ | ✓ |
| SD | Lung opacity | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Oxygen saturation decreased | ✓ | ✓ | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory failure | · | · | ✓ |
| SD | Thrombocytopenia | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release